Jupiter Asset Management LTD Sage Therapeutics, Inc. Transaction History

Jupiter Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$16.75 - $48.98 $834,032 - $2.44 Million	49,793 New	49,793 $1.02 Million
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $1.29 Million - $1.75 Million	40,137 New	40,137 $1.53 Million
Q1 2022 May 11, 2022	SELL	$30.71 - $45.71 $941,906 - $1.4 Million	-30,671 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$40.26 - $57.37 $547,536 - $780,232	-13,600 Reduced 30.72%	30,671 $1.36 Million
Q2 2021 Aug 10, 2021	BUY	$54.88 - $79.29 $1.99 Million - $2.87 Million	36,229 Added 450.5%	44,271 $2.51 Million
Q4 2020 Feb 10, 2021	BUY	$58.41 - $89.06 $469,733 - $716,220	8,042 New	8,042 $696,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.